| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |